Figure 1 | Scientific Reports

Figure 1

From: HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment

Figure 1

Flow chart showing the patient selection criteria used in the iMODE-B study (Imaging and Molecular Detection of Breast Cancer), with molecular markers at the time of breast cancer diagnosis or progression, molecular detection and imaging detection of breast cancer. BC breast cancer, DCIS ductal carcinoma in situ, HER2+ human epidermal growth factor receptor 2-positive, MaCa breast cancer, OP surgical operation, pT pathological staging, TNBC triple-negative breast cancer.

Back to article page